About
Technology
Issues
FAQ
Links
Official Page
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.